Literature DB >> 21292879

Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.

Luciane M Storti-Melo1, Wanessa C Souza-Neiras, Gustavo C Cassiano, Leonardo C Taveira, Antônio J Cordeiro, Vanja S C A Couto, Marinete M Póvoa, Maristela G Cunha, Diana M Echeverry, Andréa R B Rossit, Myriam Arévalo-Herrera, Sócrates Herrera, Ricardo L D Machado.   

Abstract

Frequency and levels of IgG antibodies to an N-terminal fragment of the Plasmodium vivax MSP-1 (Pv200L) protein, in individuals naturally exposed to malaria in four endemic areas of Brazil, were evaluated by enzyme-linked immunosorbent assay. Plasma samples of 261 P. vivax-infected individuals from communities of Macapá, Novo Repartimento, Porto Velho, and Plácido de Castro in the Amazonian region with different malaria transmission intensities. A high mean number of studied individuals (89.3%) presented with antibodies to the Pv200L that correlated with the number of previous malaria infections; there were significant differences in the frequency of the responders (71.9-98.7) and in the antibody levels (1:200-1:51,200) among the four study areas. Results of this study provide evidence that Pv200L is a naturally immunogenic fragment of the PvMSP-1 and is associated with the degree of exposure to parasites. The fine specificity of antibodies to Pv200L is currently being assessed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292879      PMCID: PMC3032491          DOI: 10.4269/ajtmh.2011.10-0044

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  36 in total

1.  Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.

Authors:  Maria Helena C Rodrigues; Karina M Rodrigues; Tatiane R Oliveira; Andréia N Cômodo; Mauricio M Rodrigues; Clemens H M Kocken; Alan W Thomas; Irene S Soares
Journal:  Int J Parasitol       Date:  2004-12-19       Impact factor: 3.981

2.  Inhibitory antibodies specific for the 19-kilodalton fragment of merozoite surface protein 1 do not correlate with delayed appearance of infection with Plasmodium falciparum in semi-immune individuals in Vietnam.

Authors:  E Elsa Herdiana Murhandarwati; Lina Wang; Casilda G Black; Doan Hanh Nhan; Thomas L Richie; Ross L Coppel
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

3.  Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria.

Authors:  I S Soares; G Levitus; J M Souza; H A Del Portillo; M M Rodrigues
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.

Authors:  A F Egan; M J Blackman; D C Kaslow
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 5.  The neglected burden of Plasmodium vivax malaria.

Authors:  K Mendis; B J Sina; P Marchesini; R Carter
Journal:  Am J Trop Med Hyg       Date:  2001 Jan-Feb       Impact factor: 2.345

6.  Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1.

Authors:  I S Soares; M G da Cunha; M N Silva; J M Souza; H A Del Portillo; M M Rodrigues
Journal:  Am J Trop Med Hyg       Date:  1999-03       Impact factor: 2.345

7.  Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection.

Authors:  I P Ceravolo; B A M Sanchez; T N Sousa; B M Guerra; I S Soares; E M Braga; A M McHenry; J H Adams; C F A Brito; L H Carvalho
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

8.  Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.

Authors:  C Uthaipibull; B Aufiero; S E Syed; B Hansen; J A Guevara Patiño; E Angov; I T Ling; K Fegeding; W D Morgan; C Ockenhouse; B Birdsall; J Feeney; J A Lyon; A A Holder
Journal:  J Mol Biol       Date:  2001-04-13       Impact factor: 5.469

9.  Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.

Authors:  Arlene E Dent; Kiprotich Chelimo; Peter O Sumba; Michele D Spring; Brendan S Crabb; Ann M Moormann; Daniel J Tisch; James W Kazura
Journal:  Malar J       Date:  2009-07-16       Impact factor: 2.979

10.  Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.

Authors:  Fiona J McCallum; Kristina E M Persson; Cleopatra K Mugyenyi; Freya J I Fowkes; Julie A Simpson; Jack S Richards; Thomas N Williams; Kevin Marsh; James G Beeson
Journal:  PLoS One       Date:  2008-10-29       Impact factor: 3.240

View more
  11 in total

Review 1.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 2.  Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Authors:  Francis B Ntumngia; Christopher L King; John H Adams
Journal:  Int J Parasitol       Date:  2012-10-12       Impact factor: 3.981

Review 3.  Progress towards the development of a P. vivax vaccine.

Authors:  Sai Lata De; Francis B Ntumngia; Justin Nicholas; John H Adams
Journal:  Expert Rev Vaccines       Date:  2021-03-04       Impact factor: 5.217

4.  Standardization and validation of a cytometric bead assay to assess antibodies to multiple Plasmodium falciparum recombinant antigens.

Authors:  Bartholomew N Ondigo; Gregory S Park; Severin O Gose; Benjamin M Ho; Lyticia A Ochola; George O Ayodo; Ayub V Ofulla; Chandy C John
Journal:  Malar J       Date:  2012-12-21       Impact factor: 2.979

5.  In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.

Authors:  Rodrigo Nunes Rodrigues-da-Silva; João Hermínio Martins da Silva; Balwan Singh; Jianlin Jiang; Esmeralda V S Meyer; Fátima Santos; Dalma Maria Banic; Alberto Moreno; Mary R Galinski; Joseli Oliveira-Ferreira; Josué da Costa Lima-Junior
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

6.  Antigenicity and immunogenicity of Plasmodium vivax merozoite surface protein-3.

Authors:  Amanda R Bitencourt; Elaine C Vicentin; Maria C Jimenez; Ricardo Ricci; Juliana A Leite; Fabio T Costa; Luis C Ferreira; Bruce Russell; François Nosten; Laurent Rénia; Mary R Galinski; John W Barnwell; Mauricio M Rodrigues; Irene S Soares
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

Review 7.  N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine.

Authors:  Fernanda G Versiani; Maria E Almeida; Luis A Mariuba; Patricia P Orlandi; Paulo A Nogueira
Journal:  Clin Dev Immunol       Date:  2013-09-28

8.  Genetic diversity of MSP1 Block 2 of Plasmodium vivax isolates from Manaus (central Brazilian Amazon).

Authors:  Leidiane Amorim Soares; Janaína Evangelista; Patricia Puccinelli Orlandi; Maria Edilene Almeida; Luciana Pereira de Sousa; Yury Chaves; Roberto Barbosa-Filho; Marcus Vinícius Lacerda; Luis André Mariuba; Paulo Afonso Nogueira
Journal:  J Immunol Res       Date:  2014-02-27       Impact factor: 4.818

9.  High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.

Authors:  Fernanda G Versiani; Maria E M Almeida; Gisely C Melo; Francivaldo O L Versiani; Patrícia P Orlandi; Luís André M Mariúba; Leidiane A Soares; Luciana P Souza; Antonio A da Silva Balieiro; Wuelton M Monteiro; Fabio T M Costa; Hernando A del Portillo; Marcus V G Lacerda; Paulo A Nogueira
Journal:  Malar J       Date:  2013-08-27       Impact factor: 2.979

10.  Immunogenetic markers associated with a naturally acquired humoral immune response against an N-terminal antigen of Plasmodium vivax merozoite surface protein 1 (PvMSP-1).

Authors:  Gustavo Capatti Cassiano; Adriana A C Furini; Marcela P Capobianco; Luciane M Storti-Melo; Maria E Almeida; Danielle R L Barbosa; Marinete M Póvoa; Paulo A Nogueira; Ricardo L D Machado
Journal:  Malar J       Date:  2016-06-03       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.